During the past decade, University Hospital Split conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 15 clinical trials were completed, i.e. on average, 25.9% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 10 clinical trials were completed. i.e. 27% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Split" #1 sponsor was "University Hospital of Split" with 8 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "University of Split, School of Medicine" with 5 trials sponsored, "Celgene" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Split" #1 collaborator was "University Hospital of Split" with 3 trials as a collaborator, "Clinical Hospital Center, Split" with 2 trials as a collaborator, "General Hospital Zadar" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator and "University of Split, School of Medicine" with 2 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Split" are "Ulcerative Colitis" (6 trials), "Atrial Fibrillation" (4 trials), "Crohn Disease" (4 trials), "Anesthesia" (3 trials) and "Appendicitis Acute" (3 trials). Many other conditions were trialed in "University Hospital Split" in a lesser frequency.

Most popular intervention types in "University Hospital Split" are "Drug" (47 trials), "Device" (12 trials), "Other" (9 trials), "Biological" (8 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Guselkumab" (4 trials), "Ozanimod" (3 trials), "Atezolizumab" (2 trials) and "Baricitinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Split" are 69 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "University Hospital Split". 1 are not yet recruiting, 20 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in University Hospital Split, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Split, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 20 trials that are defined as “Not Applicable".